 Enhanced endogenous leukotriene biosynthesis patients granulocyte-macrophage colony-stimulating factor hematopoietic cytokine granulocyte-macrophage colony-stimulating factor GM-CSF clinical trials potential treatment hematopoietic insufficiency due various causes Involvement leukotrienes effects GM-CSF analytical pharmacologic evidence vitro data support role leukotrienes GM-CSF action vivo present investigation question measurement endogenous cysteinyl leukotriene formation patients cytokine cytopenia cytostatic drugs refractory anemia excess blasts RAEB Endogenous cysteinyl leukotriene formation determination urinary leukotriene metabolites combined high-performance liquid chromatography analysis GM-CSF administration distinct increase urinary cysteinyl leukotrienes cytopenic RAEB patients cytopenic patients increase leukotriene production expansion peripheral blood leukocytes RAEB patients GM-CSF enhanced leukotriene biosynthesis peripheral leukocytes due abnormal number and/or irritability leukotriene-producing cells increase endogenous leukotriene production therapy GM-CSF leukotrienes role GM-CSF action vivo